Pentwater Capital Management »

Cerevel Therapeutics Hldng I shares owned by Pentwater Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Pentwater Capital Management from 13F filings

Historical chart of Pentwater Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Pentwater Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Pentwater Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $47M 1.1M 42.40

More positions owned by Pentwater Capital Management

Pioneer Natural Resources (PXD)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hess Put Option (HES)
stock Put Option
United States Steel Corporation Put Option (X)
Karuna Therapeutics Ord Put Option
Capri Holdings SHS Put Option (CPRI)
Boeing Company Call Option (BA)
Chevron Corporation Call Option (CVX)
Endeavor Group Hldgs Cl A Com Call Option (EDR)
ImmunoGen Put Option
Kenvue Put Option (KVUE)
Teck Resources CL B Put Option (TECK)
Exxon Mobil Corporation Call Option (XOM)
Manchester Utd Ord Cl A Put Option (MANU)

View all positions for Pentwater Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I